Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 18

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-9-16

Curated date: 2025/05/09

Curator: Ameenatoloko

Revision editor(s): Ameenatoloko, KateRasheed

Subjects

Location of subjects
United Kingdom
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to antibiotic Response to antibiotic,response to antibiotic
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Abx_mother_labour_IAP on day 21 for vaginal delivery[where Abx is antibiotics, and IAP is Intrapartum antibiotic prophylaxis]
Group 1 name Corresponds to the case (exposed) group for case-control studies
No Abx_mother_labour_IAP on day 21 for vaginal delivery[where Abx is antibiotics, and IAP is Intrapartum antibiotic prophylaxis]
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Mothers who did not receive antibiotics during labour.

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.25
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
antibiotic


Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-9-16

Curated date: 2025/05/10

Curator: Ameenatoloko

Revision editor(s): Ameenatoloko

Source: Table S5

Description: Significant metagenomic species associated with clinical covariates after adjusting for potentially confounding covariates with MaAsLin.

Abundance in Group 1: decreased abundance in No Abx_mother_labour_IAP on day 21 for vaginal delivery[where Abx is antibiotics, and IAP is Intrapartum antibiotic prophylaxis]

NCBI Quality ControlLinks
Bifidobacterium bifidum

Revision editor(s): Ameenatoloko

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-9-16

Curated date: 2025/09/16

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Table S5

Description: Significant metagenomic species associated with clinical covariates after adjusting for potentially confounding covariates with MaAsLin.

Abundance in Group 1: increased abundance in No Abx_mother_labour_IAP on day 21 for vaginal delivery[where Abx is antibiotics, and IAP is Intrapartum antibiotic prophylaxis]

NCBI Quality ControlLinks
Bifidobacterium bifidum

Revision editor(s): KateRasheed